ARCHIVES

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

This article is from The Cancer Letter archive.

Vol. 18 No. 40 | October 16, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

Trials Approved by NCI CTEP For The Month of February

February 24, 2012

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

In Congress; Senate Ok’s $185 Mil. Addition For Breast Cancer

October 2, 1992